カテゴリ： 世界, 医療/バイオ, QYResearch

持続携行式腹膜透析（CAPD）の世界市場インサイト・予測（～2028年）

■ 英語タイトル：Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Insights, Forecast to 2028

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QY22JL3709）■ 発行会社/調査会社：QYResearch
■ 商品コード：QY22JL3709
■ 発行日：2022年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：114
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[持続携行式腹膜透析（CAPD）の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

COVID-19のパンデミックにより、持続携行式腹膜透析（CAPD）のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に持続携行式腹膜透析（CAPD）の世界市場のxxx％を占める「腹膜透析セット」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「在宅透析」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
持続携行式腹膜透析（CAPD）の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの持続携行式腹膜透析（CAPD）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

持続携行式腹膜透析（CAPD）のグローバル主要企業には、Fresenius、Baxter International、Nipro、B. Braun、DaVita、Covidien、Dialysis Clinic、Medical Components、Huaren Pharmaceutical、NephroPlus、Northwest Kidney Centres、Satellite Healthcare、NxStage Medical、Renal Services、Sandor、Sichuan Kelun Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

持続携行式腹膜透析（CAPD）市場は、種類と用途によって区分されます。世界の持続携行式腹膜透析（CAPD）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
腹膜透析セット、デバイス、カテーテル、その他

【用途別セグメント】
在宅透析、透析センター＆病院ベース透析

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 持続携行式腹膜透析（CAPD）製品概要
- 種類別市場（腹膜透析セット、デバイス、カテーテル、その他）
- 用途別市場（在宅透析、透析センター＆病院ベース透析）
- 調査の目的
・エグゼクティブサマリー
- 世界の持続携行式腹膜透析（CAPD）販売量予測2017-2028
- 世界の持続携行式腹膜透析（CAPD）売上予測2017-2028
- 持続携行式腹膜透析（CAPD）の地域別販売量
- 持続携行式腹膜透析（CAPD）の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別持続携行式腹膜透析（CAPD）販売量
- 主要メーカー別持続携行式腹膜透析（CAPD）売上
- 主要メーカー別持続携行式腹膜透析（CAPD）価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（腹膜透析セット、デバイス、カテーテル、その他）
- 持続携行式腹膜透析（CAPD）の種類別販売量
- 持続携行式腹膜透析（CAPD）の種類別売上
- 持続携行式腹膜透析（CAPD）の種類別価格
・用途別市場規模（在宅透析、透析センター＆病院ベース透析）
- 持続携行式腹膜透析（CAPD）の用途別販売量
- 持続携行式腹膜透析（CAPD）の用途別売上
- 持続携行式腹膜透析（CAPD）の用途別価格
・北米市場
- 北米の持続携行式腹膜透析（CAPD）市場規模（種類別、用途別）
- 主要国別の持続携行式腹膜透析（CAPD）市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの持続携行式腹膜透析（CAPD）市場規模（種類別、用途別）
- 主要国別の持続携行式腹膜透析（CAPD）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の持続携行式腹膜透析（CAPD）市場規模（種類別、用途別）
- 主要国別の持続携行式腹膜透析（CAPD）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の持続携行式腹膜透析（CAPD）市場規模（種類別、用途別）
- 主要国別の持続携行式腹膜透析（CAPD）市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの持続携行式腹膜透析（CAPD）市場規模（種類別、用途別）
- 主要国別の持続携行式腹膜透析（CAPD）市場規模（トルコ、サウジアラビア）
・企業情報
Fresenius、Baxter International、Nipro、B. Braun、DaVita、Covidien、Dialysis Clinic、Medical Components、Huaren Pharmaceutical、NephroPlus、Northwest Kidney Centres、Satellite Healthcare、NxStage Medical、Renal Services、Sandor、Sichuan Kelun Pharmaceutical
・産業チェーン及び販売チャネル分析
- 持続携行式腹膜透析（CAPD）の産業チェーン分析
- 持続携行式腹膜透析（CAPD）の原材料
- 持続携行式腹膜透析（CAPD）の生産プロセス
- 持続携行式腹膜透析（CAPD）の販売及びマーケティング
- 持続携行式腹膜透析（CAPD）の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 持続携行式腹膜透析（CAPD）の産業動向
- 持続携行式腹膜透析（CAPD）のマーケットドライバー
- 持続携行式腹膜透析（CAPD）の課題
- 持続携行式腹膜透析（CAPD）の阻害要因
・主な調査結果

Market Analysis and Insights: Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market
Due to the COVID-19 pandemic, the global Continuous Ambulatory Peritoneal Dialysis (CAPD) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Peritoneal Dialysis Set accounting for % of the Continuous Ambulatory Peritoneal Dialysis (CAPD) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Home-Based Dialysis segment is altered to an % CAGR throughout this forecast period.
China Continuous Ambulatory Peritoneal Dialysis (CAPD) market size is valued at US$ million in 2021, while the US and Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Continuous Ambulatory Peritoneal Dialysis (CAPD) include Fresenius, Baxter International, Nipro, B. Braun, DaVita, Covidien, Dialysis Clinic, Medical Components and Huaren Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Scope and Segment
Continuous Ambulatory Peritoneal Dialysis (CAPD) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Continuous Ambulatory Peritoneal Dialysis (CAPD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Peritoneal Dialysis Set
Device
Catheter
Others
Segment by Application
Home-Based Dialysis
Dialysis Center and Hospital Based Dialysis
By Company
Fresenius
Baxter International
Nipro
B. Braun
DaVita
Covidien
Dialysis Clinic
Medical Components
Huaren Pharmaceutical
NephroPlus
Northwest Kidney Centres
Satellite Healthcare
NxStage Medical
Renal Services
Sandor
Sichuan Kelun Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

*** レポート目次（コンテンツ）***

1 Study Coverage
1.1 Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Introduction
1.2 Market by Type
1.2.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Peritoneal Dialysis Set
1.2.3 Device
1.2.4 Catheter
1.2.5 Others
1.3 Market by Application
1.3.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home-Based Dialysis
1.3.3 Dialysis Center and Hospital Based Dialysis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales Estimates and Forecasts 2017-2028
2.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue Estimates and Forecasts 2017-2028
2.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Region
2.4.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Region (2017-2022)
2.4.2 Global Sales Continuous Ambulatory Peritoneal Dialysis (CAPD) by Region (2023-2028)
2.5 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Region
2.5.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Region (2017-2022)
2.5.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Manufacturers
3.1.1 Global Top Continuous Ambulatory Peritoneal Dialysis (CAPD) Manufacturers by Sales (2017-2022)
3.1.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Continuous Ambulatory Peritoneal Dialysis (CAPD) in 2021
3.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Manufacturers
3.2.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Manufacturers (2017-2022)
3.2.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue in 2021
3.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Type
4.1.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Historical Sales by Type (2017-2022)
4.1.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Forecasted Sales by Type (2023-2028)
4.1.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales Market Share by Type (2017-2028)
4.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Type
4.2.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Historical Revenue by Type (2017-2022)
4.2.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue Market Share by Type (2017-2028)
4.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Price by Type
4.3.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Price by Type (2017-2022)
4.3.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Application
5.1.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Historical Sales by Application (2017-2022)
5.1.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Forecasted Sales by Application (2023-2028)
5.1.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales Market Share by Application (2017-2028)
5.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Application
5.2.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Historical Revenue by Application (2017-2022)
5.2.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue Market Share by Application (2017-2028)
5.3 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Price by Application
5.3.1 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Price by Application (2017-2022)
5.3.2 Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Type
6.1.1 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Type (2017-2028)
6.1.2 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Type (2017-2028)
6.2 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Application
6.2.1 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Application (2017-2028)
6.2.2 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Application (2017-2028)
6.3 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Country
6.3.1 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Country (2017-2028)
6.3.2 North America Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Type
7.1.1 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Type (2017-2028)
7.1.2 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Type (2017-2028)
7.2 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Application
7.2.1 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Application (2017-2028)
7.2.2 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Application (2017-2028)
7.3 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Country
7.3.1 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Country (2017-2028)
7.3.2 Europe Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Type
8.1.1 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Type (2017-2028)
8.1.2 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Type (2017-2028)
8.2 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Application
8.2.1 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Application (2017-2028)
8.2.2 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Application (2017-2028)
8.3 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Region
8.3.1 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Region (2017-2028)
8.3.2 Asia Pacific Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Type
9.1.1 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Type (2017-2028)
9.1.2 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Type (2017-2028)
9.2 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Application
9.2.1 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Application (2017-2028)
9.2.2 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Application (2017-2028)
9.3 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Country
9.3.1 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Country (2017-2028)
9.3.2 Latin America Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Type
10.1.1 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Type (2017-2028)
10.2 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Application
10.2.1 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Application (2017-2028)
10.3 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Size by Country
10.3.1 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Continuous Ambulatory Peritoneal Dialysis (CAPD) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Fresenius
11.1.1 Fresenius Corporation Information
11.1.2 Fresenius Overview
11.1.3 Fresenius Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Fresenius Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Fresenius Recent Developments
11.2 Baxter International
11.2.1 Baxter International Corporation Information
11.2.2 Baxter International Overview
11.2.3 Baxter International Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Baxter International Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter International Recent Developments
11.3 Nipro
11.3.1 Nipro Corporation Information
11.3.2 Nipro Overview
11.3.3 Nipro Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nipro Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nipro Recent Developments
11.4 B. Braun
11.4.1 B. Braun Corporation Information
11.4.2 B. Braun Overview
11.4.3 B. Braun Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 B. Braun Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 B. Braun Recent Developments
11.5 DaVita
11.5.1 DaVita Corporation Information
11.5.2 DaVita Overview
11.5.3 DaVita Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 DaVita Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 DaVita Recent Developments
11.6 Covidien
11.6.1 Covidien Corporation Information
11.6.2 Covidien Overview
11.6.3 Covidien Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Covidien Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Covidien Recent Developments
11.7 Dialysis Clinic
11.7.1 Dialysis Clinic Corporation Information
11.7.2 Dialysis Clinic Overview
11.7.3 Dialysis Clinic Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dialysis Clinic Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dialysis Clinic Recent Developments
11.8 Medical Components
11.8.1 Medical Components Corporation Information
11.8.2 Medical Components Overview
11.8.3 Medical Components Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Medical Components Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Medical Components Recent Developments
11.9 Huaren Pharmaceutical
11.9.1 Huaren Pharmaceutical Corporation Information
11.9.2 Huaren Pharmaceutical Overview
11.9.3 Huaren Pharmaceutical Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Huaren Pharmaceutical Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Huaren Pharmaceutical Recent Developments
11.10 NephroPlus
11.10.1 NephroPlus Corporation Information
11.10.2 NephroPlus Overview
11.10.3 NephroPlus Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 NephroPlus Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 NephroPlus Recent Developments
11.11 Northwest Kidney Centres
11.11.1 Northwest Kidney Centres Corporation Information
11.11.2 Northwest Kidney Centres Overview
11.11.3 Northwest Kidney Centres Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Northwest Kidney Centres Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Northwest Kidney Centres Recent Developments
11.12 Satellite Healthcare
11.12.1 Satellite Healthcare Corporation Information
11.12.2 Satellite Healthcare Overview
11.12.3 Satellite Healthcare Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Satellite Healthcare Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Satellite Healthcare Recent Developments
11.13 NxStage Medical
11.13.1 NxStage Medical Corporation Information
11.13.2 NxStage Medical Overview
11.13.3 NxStage Medical Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 NxStage Medical Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 NxStage Medical Recent Developments
11.14 Renal Services
11.14.1 Renal Services Corporation Information
11.14.2 Renal Services Overview
11.14.3 Renal Services Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Renal Services Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Renal Services Recent Developments
11.15 Sandor
11.15.1 Sandor Corporation Information
11.15.2 Sandor Overview
11.15.3 Sandor Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sandor Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sandor Recent Developments
11.16 Sichuan Kelun Pharmaceutical
11.16.1 Sichuan Kelun Pharmaceutical Corporation Information
11.16.2 Sichuan Kelun Pharmaceutical Overview
11.16.3 Sichuan Kelun Pharmaceutical Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Sichuan Kelun Pharmaceutical Continuous Ambulatory Peritoneal Dialysis (CAPD) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sichuan Kelun Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Continuous Ambulatory Peritoneal Dialysis (CAPD) Industry Chain Analysis
12.2 Continuous Ambulatory Peritoneal Dialysis (CAPD) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Continuous Ambulatory Peritoneal Dialysis (CAPD) Production Mode & Process
12.4 Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales and Marketing
12.4.1 Continuous Ambulatory Peritoneal Dialysis (CAPD) Sales Channels
12.4.2 Continuous Ambulatory Peritoneal Dialysis (CAPD) Distributors
12.5 Continuous Ambulatory Peritoneal Dialysis (CAPD) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Continuous Ambulatory Peritoneal Dialysis (CAPD) Industry Trends
13.2 Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Drivers
13.3 Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Challenges
13.4 Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Restraints
14 Key Findings in The Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 持続携行式腹膜透析（CAPD）のグローバル市場展望 2023年-2029年：腹膜透析セット、装置、カテーテル、その他
  • 機器輸送システム（ETS）の世界市場インサイト・予測（～2028年）
  • 頸部胸部オルソシス（CTO）の世界市場インサイト・予測（～2028年）
  • 線維芽細胞成長因子（FGF）の世界市場インサイト・予測（～2028年）
  • 電子増倍管（EMT）の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QY22JL3709 )"持続携行式腹膜透析（CAPD）の世界市場インサイト・予測（～2028年）" (英文：Global Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Insights, Forecast to 2028)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。